Drug-induced syndrome of inappropriate antidiuretic hormone secretion - Causes, diagnosis and management

被引:59
作者
Chan, TYK
机构
[1] Department of Clinical Pharmacology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin
[2] Department of Clinical Pharmacology, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories
关键词
D O I
10.2165/00002512-199711010-00004
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Hyponatraemia is common among the elderly, and may be caused by physiological changes, disease processes or drugs. About half of elderly patients with hyponatraemia have features typical of the syndrome of inappropriate antidiuretic hormone secretion (SIADH). It is important to establish whether drugs are the cause, as this is easily remediable. The clinical manifestations of SIADH are predominantly attributable to hyponatraemia and serum hypo-osmolality. The severity of the signs and symptoms depends on the degree of hyponatraemia and the rapidity with which the syndrome develops. Although a growing number of drugs have been reported to produce SIADH, most published reports concern vasopressin and its analogues, thiazide and thiazide-like diuretics, chlorpropamide, carbamazepine, antipsychotics, antidepressants and nonsteroidal anti-inflammatory drugs. Old age is a risk factor for SIADH following the use of many of these drugs. The use of these drugs in combination, excessive fluid intake and other underlying conditions that limit free water excretion increase the risk. Drug-induced SIADH usually resolves following cessation of the offending agent(s). Additional measures are required in patients with symptomatic hyponatraemia, including fluid restriction and intravenous sodium chloride and/or furosemide (frusemide) therapy. Careful monitoring is essential, with particular attention paid to the rate and extent of correction of the hyponatraemia.
引用
收藏
页码:27 / 44
页数:18
相关论文
共 215 条
[71]   PHENELZINE-ASSOCIATED INAPPROPRIATE ADH SECRETION [J].
GIESE, AA ;
LEIBENLUFT, E ;
GREEN, S ;
MORICLE, LA .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1989, 9 (04) :309-310
[72]  
GONTHIER R, 1993, PRESSE MED, V22, P176
[73]   DRUG-INDUCED HYPONATREMIA IN PSYCHOGENIC POLYDIPSIA [J].
GOSSAIN, VV ;
SUGAWARA, M ;
HAGEN, GA .
POSTGRADUATE MEDICAL JOURNAL, 1976, 52 (613) :720-722
[74]  
GREENBAUMLEFKOE B, 1985, CANCER-AM CANCER SOC, V55, P44, DOI 10.1002/1097-0142(19850101)55:1<44::AID-CNCR2820550107>3.0.CO
[75]  
2-B
[76]   HYPONATREMIA DUE TO SULFONYLUREA COMPOUNDS [J].
HAGEN, GA ;
FRAWLEY, TF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1970, 31 (05) :570-+
[77]   LIFE-THREATENING WATER-INTOXICATION DURING SOMATOSTATIN THERAPY [J].
HALMA, C ;
JANSEN, JBMJ ;
JANSSENS, AR ;
GRIFFIOEN, G ;
LAMERS, CBHW .
ANNALS OF INTERNAL MEDICINE, 1987, 107 (04) :518-520
[78]   THIAZIDE-INDUCED SYNDROME OF INAPPROPRIATE SECRETION OF ANTI-DIURETIC HORMONE - TIME COURSE OF RESOLUTION [J].
HAMBURGER, S ;
KOPRIVICA, B ;
ELLERBECK, E ;
COVINSKY, JO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 246 (11) :1235-1236
[79]   HYPONATREMIC CONVULSION ASSOCIATED WITH DESMOPRESSIN AND IMIPRAMINE TREATMENT [J].
HAMED, M ;
MITCHELL, H ;
CLOW, DJ .
BRITISH MEDICAL JOURNAL, 1993, 306 (6886) :1169-1169
[80]   SEVERE HYPONATREMIA WITH INDOMETHACIN - A MORE SERIOUS TOXICITY THAN PREVIOUSLY REALIZED [J].
HAMMERMAN, C ;
ZAIA, W ;
WU, HH .
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1985, 8 (04) :260-267